chloroquine has been researched along with quinazolines in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (29.17) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, LH | 1 |
| Balaraman, R; Gokhale, SV; Parikh, SH; Saibaba, P | 1 |
| Cheng, CC | 1 |
| Ha, SH; Shao, BR; Zhan, CQ | 1 |
| Chhabra, MB; Ruprah, NS; Sanyal, PK | 1 |
| Elslager, EF | 1 |
| Divo, AA; Geary, TG; Jensen, JB | 1 |
| Ishih, A; Miyase, T; Suzuki, T; Terada, M; Watanabe, M | 1 |
| Evans, LA; Lewis, M; Lindqvist, S; Parris, A; Reynolds, A; Sharp, P; Tighe, R; Williams, MR | 1 |
| Azas, N; Ducros, C; Gasquet, M; Hutter, S; Laget, M; Rathelot, P; Rault, S; Vanelle, P; Verhaeghe, P | 1 |
| Byer, S; Carroll, SL; Kaza, N; Kohli, L; Lavalley, NJ; Roth, KA; Turner, KL | 1 |
| Alcantara, LM; Ayong, LS; Franco, CH; Franzoi, KD; Freitas-Junior, LH; Kim, J; Lee, S; Moraes, CB | 1 |
| Ling, YH; Perez-Soler, R; Piperdi, B; Schwartz, EL; Sironi, J; Zou, Y | 1 |
| Fang, W; Li, A; Luo, S; Niu, X; Ruan, J; Shen, J; Tian, G; Zhao, P; Zheng, H | 1 |
| Bertrand, M; Correa, RJ; DiMattia, GE; Fazio, EN; McGee, J; Peart, TM; Préfontaine, M; Shepherd, TG; Sugimoto, A; Valdes, YR | 1 |
| Bokobza, SM; Devery, AM; Jiang, Y; Ryan, AJ; Weber, AM | 1 |
| Chang, YT; Huang, HJ; Hwang, MH; Lin, AM; Tang, MC; Wu, MY; Yang, JC | 1 |
| Bekerman, E; Einav, S | 1 |
| Fan, LL; Gao, S; Li, WC; Li, XQ; Liu, JT; Sun, GP; Wang, F; Wang, H; Wei, W; Yu, HQ | 1 |
| Chen, Q; Deitsch, KW; Heinberg, AR; Ukaegbu, UE; Wele, M; Zhang, X | 1 |
| Chang, J; Shi, Y; Su, C; Yang, G; Zhao, L | 1 |
| Shi, Y; Su, C; Zhao, L; Zheng, Y | 1 |
| Chen, Y; Haase, D; Li, Y; Lu, G; Ma, Y; Nenkov, M; Petersen, I; Zhou, Z | 1 |
| Bao, X; Deng, A; Li, Q; Wang, L; Wang, M; Xiang, Y; Yu, W; Zhang, B; Zhang, Y | 1 |
1 review(s) available for chloroquine and quinazolines
| Article | Year |
|---|---|
New perspectives on the chemotherapy of malaria, filariasis, and leprosy.
Topics: Amodiaquine; Aniline Compounds; Antimalarials; Chloroquine; Cresols; Dapsone; Drug Resistance; Filariasis; Folic Acid Antagonists; Guanidines; Humans; Leprosy; Malaria; Phenethylamines; Plasmodium falciparum; Pyrrolidines; Quinazolines; Quinolines; Schiff Bases; Sulfones | 1974 |
23 other study(ies) available for chloroquine and quinazolines
| Article | Year |
|---|---|
Studies on the 2,4-diamino-6-substituted quinazolines. II. Activities of selected derivatives against infections with various drug-susceptible and drug-resistant strains of Plasmodium falciparum and Plasmodium vivax in owl monkeys.
Topics: Animals; Aotus trivirgatus; Chemical Phenomena; Chemistry; Chloroquine; Drug Resistance, Microbial; Female; Haplorhini; Malaria; Male; Plasmodium falciparum; Plasmodium vivax; Pyrimethamine; Quinazolines | 1979 |
Effect of acute and chronic treatment of phenobarbital and chloroquin on the turnover of 2- [2-(3-pyridyl)vinyl] -3-o-tolyl-3,4-dihydro quinazoline-4-one (SRC-909).
Topics: Animals; Chloroquine; Female; Phenobarbital; Pyridines; Quinazolines; Rats | 1979 |
Structural similarity between febrifugine and chloroquine.
Topics: Antimalarials; Chloroquine; Models, Structural; Piperidines; Quinazolines; Structure-Activity Relationship | 1976 |
[Evaluation of the phototoxicity of five antimalarial agents and praziquantel in mice].
Topics: Animals; Antimalarials; Chloroquine; Female; Male; Mice; Naphthyridines; Photosensitivity Disorders; Praziquantel; Quinacrine; Quinazolines; Quinolines; Ultraviolet Rays | 1986 |
Chemotherapeutic efficacy of sulphadimidine, amprolium, halofuginone and chloroquine phosphate in experimental Eimeria bareillyi coccidiosis of buffaloes.
Topics: Amprolium; Animals; Buffaloes; Chloroquine; Coccidiosis; Coccidiostats; Eimeria; Intestine, Small; Piperidines; Quinazolines; Quinazolinones; Sulfamethazine | 1985 |
An in vitro assay system for the identification of potential antimalarial drugs.
Topics: Animals; Antimalarials; Cattle; Chloramphenicol; Chloroquine; Clindamycin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythrocytes; Humans; Hypoxanthine; Hypoxanthines; Piperidines; Plasmodium falciparum; Quinazolines; Quinazolinones; Rabbits | 1983 |
Combination effects of chloroquine with the febrifugine and isofebrifugine mixture against a blood-induced infection with chloroquine-resistant Plasmodium berghei NK65 in ICR mice.
Topics: Animals; Antimalarials; Chloroquine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Malaria; Male; Mice; Mice, Inbred ICR; Parasitic Sensitivity Tests; Phytotherapy; Piperidines; Plasmodium berghei; Quinazolines | 2003 |
Dynamic and differential regulation of NKCC1 by calcium and cAMP in the native human colonic epithelium.
Topics: Acetylcholine; Adult; Aged; Aged, 80 and over; Calcium; Calcium Signaling; Chloroquine; Cholinergic Agents; Colforsin; Colon; Cyclic AMP; ErbB Receptors; Humans; Intestinal Mucosa; Lysosomes; Middle Aged; Protein Synthesis Inhibitors; Quinazolines; Receptor, Muscarinic M3; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Tissue Distribution; Tyrphostins | 2007 |
Synthesis and antiplasmodial activity of new 4-aryl-2-trichloromethylquinazolines.
Topics: Animals; Antimalarials; Cell Line; Chloroquine; Drug Resistance; Humans; Hydrocarbons, Chlorinated; Plasmodium falciparum; Quinazolines | 2008 |
The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Caspases; Cell Line, Tumor; Cell Proliferation; Chloroquine; ErbB Receptors; Genes, erbB; Humans; Lysosomes; Molecular Targeted Therapy; Nerve Sheath Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
Chemosensitization potential of P-glycoprotein inhibitors in malaria parasites.
Topics: Antimalarials; Artemisinins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Boron Compounds; Chloroquine; Chlorpheniramine; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Erythrocytes; Fluorescent Dyes; Gefitinib; Humans; Imatinib Mesylate; Mefloquine; Piperazines; Plasmodium falciparum; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Quinolines | 2013 |
The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib.
Topics: Animals; Antimalarials; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Chloroquine; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Flow Cytometry; Humans; Lung Neoplasms; Mice; Mice, Nude; Protein Kinase Inhibitors; Quinazolines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2013 |
Autophagy inhibition induces enhanced proapoptotic effects of ZD6474 in glioblastoma.
Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 7; Beclin-1; Cell Line, Tumor; Cell Survival; Chloroquine; ErbB Receptors; Glioblastoma; Humans; Membrane Proteins; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; TOR Serine-Threonine Kinases; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays | 2013 |
Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Topics: Allosteric Regulation; Antineoplastic Agents; Ascites; Autophagy; Benzylamines; Cell Line, Tumor; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Quinoxalines; Spheroids, Cellular | 2014 |
Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Drug Synergism; ErbB Receptors; Female; Gefitinib; Heterocyclic Compounds, 3-Ring; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Mutation; Proto-Oncogene Proteins c-akt; Quinazolines; RNA Interference; Xenograft Model Antitumor Assays | 2014 |
Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.
Topics: Adenine; Antineoplastic Agents; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chloroquine; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Quinazolines | 2015 |
Infectious disease. Combating emerging viral threats.
Topics: Adenine; Adenosine; Antiviral Agents; Benzamides; Chloroquine; Communicable Diseases, Emerging; Cyclosporins; Cytosine; Dengue; Drug Approval; Drug Design; Erlotinib Hydrochloride; Hemorrhagic Fever, Ebola; Humans; Imatinib Mesylate; Indoles; Organophosphonates; Piperazines; Purine Nucleosides; Pyrimidines; Pyrroles; Pyrrolidines; Quinazolines; Sunitinib; Viruses | 2015 |
Autophagy Inhibition Overcomes the Antagonistic Effect Between Gefitinib and Cisplatin in Epidermal Growth Factor Receptor Mutant Non--Small-Cell Lung Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chloroquine; Cisplatin; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolines | 2015 |
A Unique Virulence Gene Occupies a Principal Position in Immune Evasion by the Malaria Parasite Plasmodium falciparum.
Topics: Antigenic Variation; Antigens, Protozoan; Azepines; Chloroquine; Gene Expression Regulation; Genetic Loci; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Hydroxamic Acids; Immune Evasion; Inhibitory Concentration 50; Malaria, Falciparum; Models, Theoretical; Piperazines; Plasmodium falciparum; Promoter Regions, Genetic; Protozoan Proteins; Quinazolines; RNA Polymerase II; Terpenes; Transcriptional Activation; Transcriptome | 2015 |
Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance.
Topics: Adenosine Triphosphate; Annexin A5; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Survival; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; Endocytosis; Fluorescein-5-isothiocyanate; Gefitinib; Humans; Intracellular Space; Nanoparticles; Necrosis; Quinazolines | 2015 |
mAb MDR1-modified chitosan nanoparticles overcome acquired EGFR-TKI resistance through two potential therapeutic targets modulation of MDR1 and autophagy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autophagy; Cell Line, Tumor; Chitosan; Chloroquine; Drug Delivery Systems; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Nanoparticles; Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2017 |
Growth inhibitory role of the p53 activator SCH 529074 in non‑small cell lung cancer cells expressing mutant p53.
Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chloroquine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lung Neoplasms; Mutation; Piperazines; Quinazolines; Signal Transduction; Tumor Suppressor Protein p53 | 2020 |
BIX-01294-enhanced chemosensitivity in nasopharyngeal carcinoma depends on autophagy-induced pyroptosis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Autophagy-Related Protein 5; Azepines; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Chloroquine; Cisplatin; CRISPR-Cas Systems; Gene Knockout Techniques; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Microtubule-Associated Proteins; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Pyroptosis; Quinazolines; Receptors, Estrogen; Signal Transduction | 2020 |